Statins have been previously shown to inhibit the tumor volume in MCF10NeuA-, MDA-MB-435- and HepG2-driven xenografts [18, 23, 24], which is in agreement with the reduced growth of MCF10.AT1-driven lesions in the current study. Here, AGTR1 is linked to neoplasm.